ScholarIQanswers from OpenAlex & ORCID
Ralph A. DeFronzo
ResearcherPublications, citations & collaboration network
Ralph A. DeFronzo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ralph A. DeFronzo have?
ScholarIQindexed works
Ralph A. DeFronzo has 408 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ralph A. DeFronzo have?
ScholarIQcitation count
Ralph A. DeFronzo has 52,207 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ralph A. DeFronzo?
ScholarIQh-index
Ralph A. DeFronzo has an h-index of 99 in OpenAlex.
What is the i10-index of Ralph A. DeFronzo?
ScholarIQi10-index
Ralph A. DeFronzo has an i10-index of 263 in OpenAlex.
What is the ORCID of Ralph A. DeFronzo?
ScholarIQorcid
The ORCID for Ralph A. DeFronzo is on the source record.
What is the OpenAlex record for Ralph A. DeFronzo?
ScholarIQopenalex
The OpenAlex for Ralph A. DeFronzo is on the source record.
What are the most-cited papers on Ralph A. DeFronzo?
ScholarIQmost cited works
Impaired Fasting Glucose and Impaired Glucose Tolerance
David M. Nathan, Mayer B. Davidson, Ralph A. DeFronzo, Robert J. Heine, Robert R. Henry, Richard E. Pratley, Bernard Zinman
Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo‐Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Robert R. Henry, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Per‐Henrik Groop, Riccardo C. Bonadonna, Stefano DelPrato, Klaus Ratheiser, K Zyck, Ele Ferrannini, Ralph A. DeFronzo
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke, MaryAnn Banerji, George A. Bray, Thomas A. Buchanan, Stephen Clement, Robert R. Henry, Howard N. Hodis, Abbas E. Kitabchi, Wendy J. Mack, Sunder Mudaliar, Robert E. Ratner, Ken Williams, Frankie B. Stentz, Nicolas Musi, Peter D. Reaven
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
Alan J. Garber, Yehuda Handelsman, George Grunberger, Daniel Einhorn, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Michael A. Bush, Ralph A. DeFronzo, Jeffrey R. Garber, W. Timothy Garvey, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Leigh Perreault, Paul D. Rosenblit, Susan L. Samson, Guillermo E. Umpierrez